How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.070
https://www.valueinhealthjournal.com/article/S1098-3015(17)30404-7/fulltext
Title : How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30404-7&doi=10.1016/j.jval.2017.08.070
First page : A409
Section Title : BREAKOUT SESSION XIV
Open access? : No
Section Order : 53
Categories :
Tags :
Regions :
ViH Article Tags :